Storys zum Thema Medizin, Gesundheit

FDX Fluid Dynamix GmbH

4

FDX Fluid Dynamix and Fraunhofer IPK to Collaborate with Lonza on Novel Nanoparticle Formulation Technology Platform FDmiX

DHL Group

2

PM: DHL Global Forwarding transportiert für kinderherzen die weltweit erste mobile Herzklinik nach El Salvador / PR: DHL Global Forwarding supports NGO kinderherzen to deliver world’s first mobile heart clinic to El Salvador

RHEACELL GmbH und Co. KG

Research Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘

LTS Lohmann Therapie-Systeme AG

First product based on LTS’ Sorrel(TM) wearable drug delivery platform launched in the US

Helmholtz Munich

Rising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Target

Koehler Group

Extension of Wastewater Treatment Plant at Koehler Paper in Kehl

Leipzig Tourismus und Marketing GmbH

5

Pioneering Heart Surgery and Medical Congresses in Leipzig

PNO Innovation GmbH

iMEDCAP: EU-Projekt leistet Pionierarbeit bei der Rettung verwundeter Soldaten

PNO Innovation GmbH

iMEDCAP: European project to pioneer the rescue of wounded soldiers from inaccessible areas

Helmholtz Munich

Therapeutic Vaccine for Chronic Hepatitis B Enters Clinical Trial

Universität Mannheim

Discrimination Impairs Mental Health Directly and Indirectly

Discrimination Impairs Mental Health Directly and Indirectly Up to now, there was some indication that discrimination negatively affects a person’s mental health and well-being. With a meta study, female researchers of the University of Mannheim show the clear negative effects of discrimination for the first time. The systematic meta study of Christine Emmer, Julia Dorn, and Professor Dr. Jutta Mata, holder of the ...

Helmholtz Munich

What Our Genetic Information Tells Us About Type 2 Diabetes Risk and Complications

Acousia Therapeutics GmbH

Hearing loss company Acousia announces first patient enrolled in its Phase 2 PROHEAR-Study

Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, just announced the randomization of the first patient for the PROHEAR-Study. The PROHEAR-Study is a placebo-controlled, Phase 2a study with split-body design, which investigates the otoprotective efficacy ...

Sysmex Europe SE

Strengthening the Direct Sales and Service System for Business Expansion in Italy

Biomay AG

Biomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapy

SHL Medical

SHL Medical partners with SteriPack Group to set up final assembly service

Intuitive Surgical Deutschland GmbH

Intuitive’s da Vinci Single-Port Surgical System Receives CE Mark / da Vinci SP approved for use in Europe across multiple procedures

Sunnyvale, Calif. (ots) - Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced that the da Vinci Single-Port (SP) surgical system has received CE mark approval for use in Europe for endoscopic abdominopelvic, thoracoscopic, transoral ...

PNO Innovation GmbH

2

OPTIMA cancer project announces the Region Uppsala as new partner

SHL Medical

SHL Medical further strengthens vertical capabilities with the acquisition of US manufacturer Superior Tooling Inc.

STADA Arzneimittel AG

Press release: STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara

STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara - Marketing authorization issued in European Economic Area for Uzpruvo®, the first biosimilar to Stelara®, a biologic therapy within ...

STADA Arzneimittel AG

Press release: Zuellig Pharma becomes STADA Philippines’ exclusive distribution partner

Acousia Therapeutics GmbH

Acousia Therapeutics attracts new investor on its path to make hearing loss a treatable disease

Tübingen (ots) - - German pioneer biotech accelerates hearing loss solution development with fresh capital boost Acousia Therapeutics GmbH, a clinical-stage biotech company developing drug candidates against acute and chronic forms of hearing loss, proudly announces Esperante Ventures as the latest addition to its esteemed group of investors. The infusion of fresh ...

Fruit Vegetables Europe

1

1

Millions of Europeans already know about the healthiest challenge: '#LongLifeChallenge'

SOS-ASSISTANCE-SERVICE GesmbH

Relaunch Gipsbomber - SOS-emergency-call-centre launches winter season

Innsbruck (ots) - Flights from Innsbruck to BENELUX are already planned and will bring injured holidaymakers home. After its launch last winter, the "Gipsbomber" is experiencing a real relaunch thanks to the SOS-Emergency-Call-Centre. "For over 17 years, there was no alternative to the DASH7 for transporting injured holidaymakers home, but now it's the Dornier 328-100 ...